Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
Chu Chen
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108394-108394
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Frontal Cortex Lipid Alterations During the Onset of Alzheimer’s Disease
Marta Moreno‐Rodríguez, Sylvia E. Perez, Jonatan Martínez‐Gardeazabal, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 4, pp. 1515-1532
Open Access | Times Cited: 7
Upregulation of the GLT-1 expression attenuates neuronal apoptosis and cognitive dysfunction via inhibiting the CB1-PKA-CREB signaling pathway in mice with traumatic brain injury
Bin Bu, Ruiyao Ma, Chengyu Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Cannabinoid-2 receptor depletion promotes non-alcoholic fatty liver disease in mice via disturbing gut microbiota and tryptophan metabolism
Weiting Cheng, Siya Pei, Jie Wu, et al.
Acta Pharmacologica Sinica (2025)
Open Access
Role of endocannabinoid neurotransmission in the insular cortex on cardiovascular, autonomic and behavioral responses evoked by acute restraint stress in rats
Ivaldo Jesus Almeida Belém-Filho, Ana Caroline Ventris de Godoy, Cristiane Busnardo, et al.
Neuropharmacology (2025) Vol. 271, pp. 110404-110404
Closed Access
Discovery of new covalent inhibitors of monoacylglycerol lipase with the nitrile warhead via SCARdock
Jiapo Wang, Xiaoyu Shi, Junlai Wang, et al.
Bioorganic Chemistry (2025), pp. 108378-108378
Closed Access
Discovery of MAGL Inhibition by Lophine Derivatives: An Unexpected Finding from Chemiluminescent Assay Development
Roberta Ottria, Silvana Casati, Ornella Xynomilakis, et al.
Molecules (2025) Vol. 30, Iss. 7, pp. 1605-1605
Open Access
Lipids and lipid signaling molecules in human milk and infant formula, a chemical characterization of relevant biochemical components
Roberta Ottria, M. Porta, Ornella Xynomilakis, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 126, pp. 109580-109580
Open Access | Times Cited: 2
Binding of the monoacylglycerol lipase (MAGL) radiotracer [3H]T-401 in the rat brain after status epilepticus
Jens D. Mikkelsen, Sanjay S. Aripaka, Cansu Bilister Eğilmez, et al.
Neurochemistry International (2024) Vol. 175, pp. 105717-105717
Open Access | Times Cited: 2
ABHD6 suppresses colorectal cancer progression via AKT signaling pathway
Xiaoyu Xiong, Changjiang Yang, Yiteng Jin, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 4, pp. 647-662
Closed Access | Times Cited: 1
Endocannabinoid-mediated rescue of somatosensory cortex activity, plasticity and related behaviors following an early in life concussion
Jérôme Badaut, Lea Hippauf, M. Malinconi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Integrating serum pharmacochemistry, network pharmacology and untargeted metabolomics strategies to reveal the material basis and mechanism of action of Feining keli in the treatment of chronic bronchitis
Zhu Zhu, Yadong Feng, Yun-Lu Zou, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118643-118643
Closed Access | Times Cited: 1
Cannabidiol partially rescues behavioral, neuroinflammatory and endocannabinoid dysfunctions stemming from maternal obesity in the adult offspring
Fernanda da Silva Rodrigues, Jeferson Jantsch, Gabriel de Farias Fraga, et al.
Neuropharmacology (2024) Vol. 262, pp. 110196-110196
Closed Access | Times Cited: 1
Maternal Immune Activation and Endocannabinoid System: Focus on Two-Hit Models of Schizophrenia
Michele Santoni, Marco Pistis
Biological Psychiatry (2024)
Open Access | Times Cited: 1
Gut Microbiota-Mediated Alterations of Hippocampal CB1R Regulating the Diurnal Variation of Cognitive Impairment Induced by Hepatic Ischemia–Reperfusion Injury in Mice
Zhigang He, Yanbo Liu, Zhen Li, et al.
Neurochemical Research (2024) Vol. 49, Iss. 8, pp. 2165-2178
Closed Access | Times Cited: 1
Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS
Armin Kouchaeknejad, Gunter van der Walt, Maria Helena de Donato, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15829-15829
Open Access | Times Cited: 3
Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina
Sofia Papadogkonaki, Dimitris Spyridakos, Emmanouela Lapokonstantaki, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15689-15689
Open Access | Times Cited: 3
THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation
Nicolás Lamanna‐Rama, Diego Romero‐Miguel, Marta Casquero‐Veiga, et al.
Psychiatry Research (2023) Vol. 331, pp. 115643-115643
Closed Access | Times Cited: 3
Major Bioactive Prenylated Flavonoids from Humulus lupulus L., Their Applications in Human Diseases and Structure-Activity Relationships (SAR) – A Review
Ferah Cömert Önder, Sevil Kalin, Nebahat Sahin, et al.
Pharmaceutical Sciences (2023) Vol. 30, Iss. 1, pp. 1-20
Open Access | Times Cited: 2
Novel Heterocyclic Compounds as Monoacylglycerol Lipase Inhibitors for Treating Multiple Diseases
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 7, pp. 994-995
Open Access
Design and discovery of anthranilamide derivatives as a potential treatment for neurodegenerative disorders via targeting cholinesterases and monoamine oxidases
Sumera Zaib, Imtiaz Khan, Hafiz Saqib Ali, et al.
International Journal of Biological Macromolecules (2024) Vol. 272, pp. 132748-132748
Closed Access
PCSK9 inhibitor effectively alleviated cognitive dysfunction in a type 2 diabetes mellitus rat model
Yang Yang, Yeying Wang, Yuwen Wang, et al.
PeerJ (2024) Vol. 12, pp. e17676-e17676
Open Access
Landscape of the Lumbar Cartilaginous End Plate Microbiota and Metabolites in Patients with Modic Changes
Sunqi Nian, Shaohua Tang, Shiqian Shen, et al.
Journal of Bone and Joint Surgery (2024) Vol. 106, Iss. 20, pp. 1866-1875
Open Access
Overabundant endocannabinoids in neurons are detrimental to cognitive function
Dexiao Zhu, Jian Zhang, Xiaokuang Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy
Sonia Burgaz, Elisa Navarro, Santiago Rodríguez-Carreiro, et al.
Behavioral and Brain Functions (2024) Vol. 20, Iss. 1
Open Access
The causal effects of dietary component intake and blood metabolites on risk of delirium: a Mendelian randomization study
Qian Zhu, Yingjian Liu, Xiaona Li, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Page 1 - Next Page

Scroll to top